Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-20-033824
Filing Date
2020-06-03
Accepted
2020-06-03 11:09:56
Documents
3
Period of Report
2020-06-01

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4016
2 POA DOCUMENT poa.txt EX-24.4_919452 4037
3 EX-24 DOCUMENT attachment1.htm EX-24 4075
  Complete submission text file 0001209191-20-033824.txt   13464
Mailing Address 1717 W COLLINS AVENUE ORANGE CA 92867
Business Address
WALLER GREGORY D (Reporting) CIK: 0001204144 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37383 | Film No.: 20939285

Mailing Address 4222 E. THOMAS RD SUITE 320 PHOENIX X1 85018
Business Address 202 COUSTEAU PLACE SUITE 200 DAVIS X1 95618 602-429-0471
Arcadia Biosciences, Inc. (Issuer) CIK: 0001469443 (see all company filings)

EIN.: 810571538 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2870 Agricultural Chemicals